Amit Praful Khandhar

This inventor holds 23 USPTO granted patents and 10 published patent applications and 1 EPO patent, primarily in RNA Delivery Systems. Top assignees: Hdt Bio Corp., Access to Advanced Health Institute, Infectious Disease Research Institute. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amit Praful Khandhar. Retrieved from https://idiyas.com/inventor/amit-praful-khandhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 10)

% Patents Active = 91.3

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 93(Granted Patents)

Location History:

Bothell, WA (US) (2016)
Redmond, WA (US) (2021)
Seattle, WA (US) (2017 - 2023)
Issaquah, WA (US) (2023 - 2024)

Company Filing History:

Access to Advanced Health Institute

patents

2 out of 34

Infectious Disease Research Institute

patents

4. 2 out of 2,172

University of Washington

patents

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

RNA Delivery

RNA Vaccines

Lipid Nanoparticles

Nanostructured Carriers

Nanoparticles

SARS-CoV-2

Infectious Diseases

Nanoalum Particles

Coated Magnetic Nanoparticles

Biomedicine

Emulsions

Nucleic Acids

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433957 - Compositions and methods for delivery of RNA (2025-10-07),

2. 12427116 - Nanoalum particles containing a pegylated lipid sizing agent (2025-09-30),

3. 12350329 - RNA vaccines against infectious diseases (2025-07-08),

4. 12257299 - SARS-CoV-2 RNA vaccine compositions and methods of use (2025-03-25),

5. 12233160 - Dried nanoparticle compositions (2025-02-25),

6. 12201722 - Nanostructured lipid carriers and stable emulsions and uses thereof (2025-01-21),

7. 12133894 - Compositions and methods for delivery of RNA (2024-11-05),

8. 11896677 - Compositions and methods for delivery of RNA (2024-02-13),

9. 11752218 - Nucleic acid-small diameter and liquid core nanoparticle complexed compositions (2023-09-12),

10. 11679163 - Compositions and methods for delivery of RNA (2023-06-20),

11. 11654200 - Compositions and methods for delivery of RNA (2023-05-23),

12. 11648322 - Compositions and methods for delivery of RNA (2023-05-16),

13. 11648321 - Compositions and methods for delivery of RNA (2023-05-16),

14. 11559584 - Compositions and methods for delivery of RNA (2023-01-24),

15. 11534497 - Compositions and methods for delivery of RNA (2022-12-27),

Title: Spotlight on Inventor Amit Praful Khandhar

Introduction:

Amit Praful Khandhar, an innovative inventor hailing from Bothell, WA (US), has made significant strides in the field of nanoemulsion compositions for delivering bioactive agents like nucleic acids. With an impressive portfolio of 15 patents, Amit's work is shaping the future of biomedical applications.

Latest Patents:

Amit's latest patents showcase his expertise in developing cutting-edge nanoemulsion compositions for effective delivery of nucleic acids. His inventions focus on utilizing a hydrophobic core based on inorganic nanoparticles in a lipid nanoparticle, enabling targeted imaging and delivery of bioactive agents. These advancements open new possibilities for treatments and vaccinations in the medical field.

Career Highlights:

Amit Praful Khandhar has been associated with prominent organizations such as Hdt Bio Corp. and the Infectious Disease Research Institute. His innovative research and patented technologies have garnered recognition within the scientific community, positioning him as a thought leader in the field of nanomedicine.

Collaborations:

Throughout his career, Amit has collaborated with esteemed professionals like Jesse Erasmus and Steven G Reed. Together, they have contributed to groundbreaking research projects that aim to revolutionize drug delivery systems and enhance therapeutic outcomes in healthcare.

Conclusion:

Inventor Amit Praful Khandhar's dedication to advancing nanoemulsion technology for medical applications has solidified his reputation as a pioneering figure in the industry. His patents stand as a testament to his ingenuity and commitment to driving innovations that have the potential to positively impact the lives of many.

Profile summary based on public USPTO records.